Open access now and what’s next

Open access now and what’s next - Slavka Baronikova

9:45 AM - 10:20 AM

Open access, at a minimum level, refers to peer-reviewed, full research articles, accepted for publication to be available online, on demand and read without charge to end users. 1,2,3,4
Most medical journals publishing (pre-)clinical research offer some form of Open Access for manuscripts followed by various usage rights (typically through Creative Commons licenses [CCLs]).5
Many public/non-profit research funders (including European Research Council, NIH, Wellcome Trust, Bill & Melinda Gates Foundation) introduced mandatory Open Access in their publication policies to enhance research exchange and transparency. Also, pharmaceutical industry, as one of the biggest funders of (clinical) research, is following this trend. However, many journals offer different CCLs to research funded by industry compared to non-industry funders, and some high tier medical journals do not offer Open Access to industry funded research at all.
As part of the interactive Expert Seminar Session, ‘Where is publishing going?’, we will present a background on Open Access publishing (including OA types and CCLs), discuss status and practical implications of Open Access publishing as well as the initiatives related to transparent and barrier-free access to research via Open Access.